Mechelen, Belgium; November 3, 2025, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced that it will present new and updated data for CAR T-cell therapy candidate, GLPG51011, at the ...

The collaboration combines Shaare Zedek's real-world data and clinical expertise with Imagene AI's Oncology Intelligence Suite to advance biomarker discovery and accelerate precision cancer care. TEL ...

Answer ALS today announced the full release of its comprehensive ALS clinical and multi-omics dataset, marking the culmination of a multi-year research program and a groundbreaking collaboration with ...

High-paying remote finance director jobs often involve managing accounting and financial control functions, establishing ...

Here’s a fresh 160-character meta description based on the updated article: Osterweis Capital Management reviews Q3 results ...

Osterweis Capital Management reviews Q3 2025 small cap growth trends, highlighting AI tailwinds, key exits, and standout ...

Dose-dependent mean reductions of Activin E of up to 85% one month post single dose of WVE-007 in INLIGHT clinical trial, exceeding levels that led to weight loss in preclinical models; WVE-007 is gen ...

Douthat: It’s worth noting that your company is named for seeing stones used to view things at a very long distance in J.R.R.

First clinical data disclosure for CB-011 highlights its potential as a best-in-class allogeneic CAR-T cell therapy for relapsed or refractory multiple myeloma 450 million cell dose is the recommended ...

Progress in women’s health has gained momentum in recent years, yet major challenges remain. Persistent stigma, gaps in ...

Supports ISAC in Mission to Extend Flow Cytometry Reach Worldwide; Unveils Programs Offering Instrument Award and Research Grants ...

A start-up should always have a “plan B” to provide a critical safety net. A considerable and expensive amount of redundant lab equipment can sit idle if that pivot arises and prompts a significant ...